|
Gopal Thinakaran, PhD
Associate Professor
Department of Neurobiology
The University of Chicago
947 E. 58th St., MC0926
Chicago, IL 60637
Email: gopal@uchicago.edu
Phone: (773) 834-3752
Office: JFK R212/Knapp Center
|
Research
Description
Cellular and molecular biology
of Alzheimer's disease
For
the past several years, my research efforts have been directed towards
understanding the molecular events that underly the pathogenesis of
Alzheimer’s disease (AD). AD, a
progressive neurodegenerative disorder, is the most common cause of
dementia in the elderly, effecting ~7 - 10% of individuals over 65
years of age. The prevalence of this
disease increases to 40% in persons over 80 years of age.
Approximately 5 - 10 % of AD, classified
as early-onset familial AD (FAD) (age of onset < 60 years), is
inherited in an autosomal dominant manner and in some of these
pedigrees, mutations in genes encoding the amyloid precursor protein
(APP), presenilin 1(PS1) and presenilin 2 (PS2) cosegregate with FAD. Mutations in PS1/PS2 account
for the majority of the cases of FAD.
Pathological
lesions called senile plaques found in the brains of AD patients
contain extracellular deposits of 40-42 amino acid-long peptides,
termed b-amyloid
(Ab). Aβ holds a central
position in AD pathogenesis; it is generated by sequential
endoproteolytic processing of amyloid precursor protein (APP) by BACE
and γ-secretase. BACE is a transmembrane aspartyl protease and γ-secretase is a
multiprotein complex containing presenilin 1 (PS1) or presenilin 2
(PS2), nicastrin, APH-1 and PEN-2. FAD-linked
APP and PS1 variants enhance the production of highly amyloidogenic Ab42 peptides. The precise mechanisms involved in g-secretase
cleavage of APP, and the manner in which FAD-linked mutations favor the
production of Ab42
remain unclear.
There has been
considerable epidemiological interest in the relationship between
cholesterol and susceptibility to AD. We
are particularly interested in the cell biology of g-secretase
and amyloidogenic processing of APP in cholesterol- and
sphingolipid-rich membrane microdomains, termed lipid rafts. In addition, we are also investigating the
role of presenilins in synaptic function using cell biology,
electrophysiology, and live imaging strategies. Our
goal is to uncover information critical for the development of rational
therapeutic strategies for the treatment of AD.
Neuronal Stress
Response
In diseases such
as triplet disorders, and prion diseases, mutations in specific genes
lead to misfolding of the encoded protein products and other cellular
proteins. Thus, regardless of the
etiology, several neurodegenerative diseases are characterized by the
accumulation of misfolded proteins within the secretory pathway,
cytoplasm or nucleus, and the association between protein aggregation
and neurodegenerative diseases is an emerging field of study. My lab is interested in protein folding stress
within the secretory pathway. We are
investigating the ER stress-related gene expression with the aim of
identifying common features involved in hypoxic and ischemic neuronal
damage, aging, and neurodegeneration. These
investigations utilize a variety of cell culture systems and
well-characterized transgenic mouse models of FAD.
Our goal is to characterize the cellular
and molecular cascade of early events that lead to the
etiopathogenesis of AD and other neurodegenerative disorders.
Selected Publications
Vetrivel KS,
Meckler X, Chen Y, Nguyen PD, Kounnas MZ and Thinakaran G:
Alzheimer disease Aβ production in the absence of
S-palmitoylation-dependent
targeting of BACE1 to lipid rafts. J.
Biol. Chem. 284:3793-803, 2009.
Chen
H, Vetrivel KS, Drisdel R, Li T,
Carter M, Gong P, Chen Y, Nguyen PD, Placania L, Li Y-M, Wong PC, Green
WN,
Kounnas MZ and Thinakaran G: S-palmitoylation of γ-secretase subunits. J. Biol. Chem. 284:1373-1384, 2009.
Thinakaran
G, and Koo EH: APP trafficking,
processing and function. J. Biol. Chem.
283:29615-29619, 2008.
Vetrivel KS, Kodam A, Chen Y, Parent A, Kar S and Thinakaran G:
Cellular
distribution of p23/TMP21 in the brain. Neurobiol.
Dis. 32:37-49, 2008.
Cheng
H, Vetrivel KS,
Gong P, Meckler X, Parent AT, and Thinakaran G: Mechanisms of Disease:
new
therapeutic strategies for Alzheimer’s disease—targeting amyloid
precursor
protein processing in lipid rafts. Nature
Clinical Practice Neurology, 3:374-82, 2007.
Vetrivel
KS, Gong P, Bowen JW, Cheng H,
Chen Y, Carter M, Nguyen PD, Placanica L, Wieland FT, Li YM, Kounnas MZ
and
Thinakaran G: Dual roles of the transmembrane protein p23/TMP21 in the
modulation of amyloid precursor protein metabolism. Mol
Neurodegener. 2007 Feb 8;2(1):4.
Vetrivel
KS, Cheng H, Kim SH, Chen Y,
Barnes NY, Parent AT, Sisodia SS and Thinakaran G: Spatial segregation
of
γ-secretase and substrates in distinct membrane domains. J.
Biol. Chem. 280:25892-25900, 2005.
Parent
AT, Barnes NY,
Taniguchi Y, Thinakaran G, and Sisodia SS: Presenilin attenuates
receptor-mediated
signaling and synaptic function. J.
Neurosci. 25: 1540-1549, 2005.
Vetrivel KS, Cheng H, Sakurai T, Li T, Nukina N, Wong PC, and
Thinakaran G:
Association of γ-secretase complex with lipid raft microdomains in
post-Golgi
and endosomes membranes. J. Biol. Chem.
279: 44945-44954, 2004.
Ito
D, Walker JR, Thompson CS, Moroz I, Lin
W, Veselits ML, Hakim AM, Fienberg AA, and Thinakaran G:
Characterization of
stanniocalcin 2, a novel target of the mammalian unfolded protein
response with
cytoprotective properties. Mol. Cell.
Biol. 24: 9456-69, 2004.
Takasugi
N, Tomita T, Tsuruoka M, Hayashi
I, Takahashi Y, Thinakaran G, and Iwatsubo T: Differential Roles of
Presenilin
Cofactors in the Formation and Function of γ-Secretase Complex. Nature 422: 438-441, 2003.
Sato
N, Urano F, Yoon Leem J, Kim SH, Li M,
Donoviel D, Bernstein A, Lee AS, Ron D, Veselits ML, Sisodia SS,
Thinakaran
G. Upregulation of BiP and CHOP by the
unfolded-protein response is independent of presenilin expression. Nat
Cell Biol. 212: 863-70, 2000.
top
|
 |